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Abstract
A phenomenological rate equation model is constructed to numerically simulate nanoparticle
uptake and subsequent cellular response. Polyamidoamine dendrimers (generations 4-6) are
modelled and the temporal evolution of the intracellular cascade of; increased levels of reactive
oxygen species, intracellular antioxidant species, caspase activation, mitochondrial membrane
potential decay, tumour necrosis factor and interleukin generation is simulated, based on
experimental observations.
The dose and generation dependence of several of these response factors are seen to well
represent experimental observations at a range of time points. The model indicates that variations
between responses of different cell-lines, including murine macrophages, human keratinocytes
and colon cells, can be simulated and understood in terms of different intracellular antioxidant
levels, and, within a given cell-line, varying responses of different cytotoxicity assays can be
understood in terms of their sensitivities to different intracellular cascade events.
The model serves as a tool to interpolate and visualise the range of dose and temporal
dependences and elucidate the mechanisms underlying the in vitro cytotoxic response to
nanoparticle exposure and describes the interaction in terms of independent nanoparticle
properties and cellular parameters, based on reaction rates. Such an approach could be a valid
alternative to that of effective concentrations for classification of nanotoxicity and may lay the
foundation for future quantitative structure activity relationships and predictive nanotoxicity
models.
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Introduction
Research involving nanoparticles has seen a huge increase in recent years. This is undoubtedly
due to the novel properties these particles possess and their potential uses in a variety of fields
including: medicine, electronics, engineering, cosmetics, food, textiles, packaging and many
more.1
Medical applications is a sector where nanomaterials have shown great potential and have
already been used in several areas including: in vivo and in vitro diagnostic tools, biocompatible
materials for implants, nutraceuticals, cancer therapy and, in particular, drug delivery.2-8 In terms
of drug delivery, this interest is due to properties such as the ability to cross biological barriers
easier than some more traditional delivery vehicles and the potential to escape from intracellular
compartments such as lysosomes and endosomes.9 A full list of properties and potential uses for
nanoparticles in drug delivery is somewhat outside the scope of this paper and has been reviewed
elsewhere (De Jong et al., 2008).10 While the avenue of new medical applications does look
promising, it has been found that some nanoparticles, when exposed to mammalian cells, elicit a
toxic response.11
In vitro studies indicate this toxicity to be the result of oxidative stress, manifest as increased
Reactive Oxygen Species (ROS) production shortly after endocytosis,12 with subsequent
trafficking of the nanoparticle seen to occur through endosomes and lysosomes.13,14 The
oxidative stress leads to a release of inflammatory factors15,16,17,18,19,20,reviewed by 21 and potential
activation of apoptotic pathways.22,23,24,25 It is also important to consider processes such as
endosomal rupture (endosomolysis),9,14 which can enhance the toxic response as released
nanoparticles have been shown to localise in and subsequently damage organelles such as the
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mitochondria.15,16 If medical applications are to remain a viable option for nanomaterials, then it
will be essential to explore and better define the mechanisms involved in the toxic response.
However, in the majority of current studies, in vitro toxicity is quantified using the effective
concentration for 50% loss of viability (EC50) endpoint as an indicator of overall toxic effect. The
EC50, is the result of a complex cascade of events which occur between the initial exposure and
cell death; it gives no indication of the mechanisms, kinetics or efficacy of the interim processes.
Additionally, the measured EC50 is dependent on the assay employed and the responses of
different cell lines to the same exposure conditions have been shown to vary significantly.16
Coupled with the broad range of nanoparticle compositions, structures, sizes and possible surface
functionalisations, the result is a vast array of studies from which it is difficult to derive clear
systematic trends.
A more rationalised approach to nanotoxicity classification is becoming increasingly important
because, as more and more nanoparticles are made available, testing via a case-by-case approach
will not be sufficient.26,27 If nano-toxicology, and by extension nanomedicine, is to advance, the
focus should be on:
(i) Identification of the particle based properties which induce the cellular response,
(ii) The cellular parameters which result in variations in that response, and
(iii) The variability introduced by the use of different assays.
By doing this, it may be easier to elucidate processes and events which are common to a large set
of nanoparticles. Initial screening methods should be conducted in vitro, as there is a drive for a
reduction in the use of animal models for evaluating toxicity, due to regulatory developments in
both the EU and US (EU Directive-2010/63/EU and US Public Law 106-545, 2010, 106th
4

Congress)28,29 generally based on the 3 R’s of Russell and Burch30 to replace, reduce and refine
the use of animals used for scientific purposes. Therefore, there is currently much promotion of
the development of in vitro models which can accurately infer in vivo results. One strategy to
help meet these requirements, recently endorsed by the OECD,31 is the analysis of Adverse
Outcome Pathways (AOPs), by which a sequential chain of causally linked events at different
levels of biological organization that lead to an adverse health or ecotoxicological effect is
identified. The aim of the development of AOP is to i) guide the development of (in vitro) Test
Guidelines, ii) provide a basis for the design of Integrated Approaches to Testing and Assessment
(IATA), and iii) guide the development of molecular profilers for the QSAR toolbox. A QSAR32
(Quantitative Structure Activity Relationship) can be used to identify and model traits which are
common to entire sets of nanoparticles and hopefully elucidate how these properties/traits impact
the overall toxicity. By advancing the knowledge of these models, it is hoped that, eventually, it
will be viable to predict the full toxic profile of a cell which has taken up a nanoparticle.33
In the field of nano-toxicology (in vitro), the endpoint is usually the median EC50 of a
colorometric assay, but the choice of both assay and cell-line is large and little consideration has
been given to the different modes of action of the assay within the cell. Many studies have
explored the mechanisms underlying the toxic response, but little attention has been devoted to
quantifiable comparison between different particles or cell lines, and relationship between
endpoint and nanoparticle properties. The domain of nanoparticles is vast, but the paucity of
systematic studies renders it difficult to establish domains of applicability of any structureactivity paradigm, and therefore to define unambiguous algorithms or to validate based on
statistical goodness-of-fit, robustness and predictability.
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In the drive to develop a better understanding of the structural dependence of toxicity and
mechanisms, studies using a homologous series of nanoparticles with systematically varied
physico-chemical properties can play a vital role. Systematic variations of cellular uptake and
mechanisms of response, such as oxidative stress and inflammatory responses can be compared
to the systematic changes in the physico-chemical properties of the nanoparticle. A better
quantitative understanding of the mechanisms of response allows a better insight into the
function of the cytotoxicity assays, and how the endpoints vary systematically with nanoparticle
properties, but also with cell line, ultimately laying the foundation for the development of
quantitatively predictive models for cellular response.27
Polyamidoamine (PAMAM) dendrimer nanoparticles are a homologous series of nanoparticles of
well defined physico-chemical properties which are systematically variable and elicit
systematically variable cellular responses. PAMAM dendrimers are branched in conformation
and consist of three main parts, (i) the initiator core, (ii) the interior branches and (iii) the
exposed branch termini.34 Each set of these branches is called a Generation (G) and the
generation determines the number of surface amino groups according to the formula:

N amg  N BP(G 0) .2 G

Equation (1)

where Namg is the number of surface amino groups, NBP(G0) is the number of initial branching
points at generation zero (G0) and G denotes the generation number. Thus, the diameter and
number of surface amino-groups increases systematically with increasing generation.
This well defined branched system allows for the variation of parameters such as: Terminal
modification via addition of cationic, anionic or neutral molecules, zeta potential and in
particular generation, which will govern: number of amino groups and therefore effective surface
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charge, diameter and overall particle size. Ultimately this system lets us examine how these
characteristics impact the cell-nanoparticle interaction and therefore may shed light on the
processes involved in toxicity. Previous studies of exposure of aquatic species35 and in vitro
mammalian cell cultures16,23 have demonstrated that the polymeric dendrimer series with
systematically varied structures elicits toxic responses which are well correlated with the
variations in physico-chemical properties.
Uptake of these PAMAM dendrimers occurs via endocytosis, where the nanoparticle is
enveloped in cellular membrane and transported into the cell.23,36,37 The toxic response has been
shown to derive from an increased production of intracellular Reactive Oxygen Species (ROS)
after endocytosis.17 The ROS production is counteracted by cellular anti-oxidants, one example
of these being Glutathione (GSH), a thiol based tri-peptide.38 After this, a cascade of different
events and the release of several characteristic cytokines and chemokines occurs. Studies have
shown that, for PAMAM dendrimers in HaCaT cells, an immortalized human keratinocyte line,
activation of caspases 8 and 3 occurs at around 1-2 hrs, followed by mitochondrial membrane
potential decay (MMPD) (3-4hrs), after which there is a release of TNF-α (4-5hrs) and eventually
IL-8 which then maximises at 24 hours.38 It has also been proposed that larger generation
dendrimer nanoparticles and/or doses can cause the endosome to rupture (endosomolysis), via the
so-called proton pump mechanism.39,40,41 Supported by the fact that after ~16hrs the PAMAM
dendrimers have been seen to be located in the mitochondria,22,38 whereupon the oxidative stress
is further increased, resulting in further MMPD, which can culminate in apoptosis. A similar
inflammatory cascade has been reported in murine macrophages, although the evolution of the
responses was observed to be somewhat slower.17
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In both cases, the temporal profile was seen to be systematically dependent on dendrimer
generation and dose, pointing towards the basis of potential structure property relationships.
However, more than a single measurement at a single time point by a cytotoxic assay, the
measurement of the time evolution of the cascade provides a clearer picture of the set of events
and the visualisation of different timescales allows for a better evaluation of differences due to
nanoparticle properties and cell lines.
It is proposed that, by measuring and numerically modelling the kinetics of the cellular responses
and their dependence on nanoparticle properties, a more intuitive formulism of the nanotoxic
response which more clearly tracks the cellular response related to nanoparticle properties can be
established. The approach lends itself naturally to an AOP formalism, but the systems biology
like approach adds quantification of the rates of response, which are related to the physicochemical properties of the nanoparticles, such that the approach may ultimately lead to QSARs
and predictive models of cytotoxic response. These predictive models would be able to provide
some preliminary data on toxicity which could be used to inform initial testing strategies.
The model presented in this study looks at PAMAM toxicity based on previously published
experimental data.16,17,23,35,38 A preliminary form of the model faithfully reproduced the time
course of the toxic responses of the HaCaT cell-line to PAMAM dendrimer exposure, including
the experimentally observed generation dependence.38 This study critically extends the model to
the dose dependent responses of cell lines to nanoparticle exposure, and elucidates the origin of
the dependence of EC50 on cell-type and cytotoxic assay dependent results. The approach argues
for a classification of toxic responses based on activity of the particles, expressed as particle and
cell dependent reaction rates, rather than Effective Concentration end points.
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Materials and Methods
Experimental results are derived and adapted from previous work by the authors16,17,23,35,38 and
details of the materials and methods used can be viewed in these publications. However, below is
a brief summary of the experimental methods employed.
Naha et al. detail the dose and generation dependence of the toxic responses of murine
macrophages, the J774A.1 cell line, to exposure to PAMAM generations G4, G5 and G6. The
J774A.1 cells were cultured in Dublecco’s Modified Eagle’s Medium (DMEM), supplemented
with 10% FBS, 2mM L-Glutamine and 45IU/mL streptomycin and penicillin at 37˚C in 5% CO2.
The following exposure dose ranges were used: 0.08µM to 6µM for G4, 0.03µM to 2µM for G5
and 0.013µM to 1µM for G6. For all generations, the dose dependence of ROS production was
monitored by the fluorimetric assay, Carboxy-H2DCFDA and was performed in black 96 well
plates with a cell concentration of 4x105cells/mL. DMEM was used as a negative control and
H2O2 was used as positive control. Readings were taken at 1hr, 2hrs, 4hrs and 6hrs, with λex
(excitation wavelength) = 485nm and λem (emission wavelength) = 520nm. The temporal
evolution of the inflammatory cascade of TNF-α and Interleucin 6 (IL-6) was monitored at a
fixed dose of 1μM using the ELISA assay, where LPS was used as a positive control to verify the
procedure and the absorbance was read at 405nm. Cytotoxicity was measured using the MTT
assay, with 0.5mg/mL dye concentration and readings were take for time points: 6hrs, 12hrs,
24hrs, 48hrs and 72hrs, at an absorbance of 595nm.17,38
Mukherjee et al. detail the dose and generation dependences of the toxic responses of the
immortalised human keratinocyte (HaCaT) and primary adenocarcinoma colon (SW480) cell
lines. The cell lines were cultured in the same conditions as described above using DMEM F12
HAM and with an additional 1μg/mL hydrocortisone added for the HaCaT cells. The following
9

exposure dose ranges were used: 0.01µM to 21.1µM for G4, 0.03µM to 5.2µM for G5 and
0.01µM to 5.168µM for G6. Dose and generation dependent cytotoxicity for both cell lies was
measured using the MTT, Alamar Blue and Neutral Red assays at 24hrs. The MTT assay was
performed with 5mg/mL dye concentration and read at an absorbance of 595nm. Alamar Blue
and Neutral Red were performed in the same 96 well plates which were seeded at a concentration
of 1x105 cells/mL. Alamar Blue was performed with a concentration of 5% [v/v] and results were
measured using a fluorimeter with the λex = 485nm and λem = 520nm. Neutral Red was performed
with a dye concentration of 1.25% [v/v] and results were measured using a fluorimeter with the
λex = 531nm and λem = 642nm. The temporal evolutions of ROS, apoptosis and DNA damage
were monitored for the HaCaT cell line. ROS was again measured with the Carboxy-H2DCFDA
and was performed with a cell concentration of 1x105cells/mL. Readings were taken between 14hrs and at 24hrs for HaCaT cells, and between 30mins-6hrs and at 24hrs for SW480 cells with
λex = 490nm and λem = 545nm. Apoptosis was measured with flow cytometry, using the YOPRO-1/Propidium dyes at a concentration 1μL per 1x106cells/mL. The TUNEL assay was used to
detect DNA damage at a time point of 24hrs.16,23
Numerical results for all equations were obtained by integration using the iterative Euler
approach42 and SigmaPlot™ (v.10.0) was used to generate the values and graphs.
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Results
Generation of the Equations
In order to better visualise the full range of dose and temporal dependencies and elucidate the
mechanisms of response, the system was modelled using a relatively simple phenomenological
rate-equation model. This model is similar, in concept, to ones commonly employed for
modelling molecular-photodynamics.43
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Scheme 1. Schematic of systematic sequence of events upon nanoparticle uptake.
A schematic representation of the sequence of events upon nanoparticle uptake, where the cell
(system) takes up a particle, progresses to ROS damage (quenched by anti-oxidants), then onto
mitochondrial damage, inflammatory cascade and finally apoptosis (if the cellular recovery rates
are insufficient).

Scheme 1 illustrates the systematic sequence of events which can occur when a nanoparticle is
taken into a mammalian cell. 1: Upon exposure, the cells take up nanoparticles at a rate kendo,
leading to two populations: cells without nanoparticles (i.e. in a ground/non-toxic state), Nground,
and cells with an endocytosed nanoparticle Nendo. Also indicated is a possible “exocytosis”
process, occurring at a rate kexo. However, Salvati et al. have indicated that this does not occur for
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polymeric nanoparticles and therefore it is not included in the equations.14 2: The next step in the
sequence is ROS generation at a rate kROS, again generating a new population NROS. The ROS can
then be quenched by the action of antioxidants, at a rate denoted here by kq. 3: Alternatively, the
system progresses to mitochondrial damage at a rate kmito. 4: This process continues through a
cascade and can culminate in apoptosis if the cellular recovery rates (krec) are not sufficient.
The complex system illustrated schematically in Scheme 1 can be better described using a series
of rate equations. The process of nanoparticle endocytosis by cells in vitro, taking into account
the cell replication rate (kλ), has previously been described by Salvati et al.14 and is here
described by Equation 2. As the dose (D) is expressed as the molar dose, for ease of comparison
with the experimental data, Nendo is an expression of the molar quantity (number per unit volume)
of endocytosed dendrimer nanoparticles. In subsequent equations, the term “N” is used to denote
the equivalent quantity denoted by the subscript text that follows.

dNendo
 k endo .(N amg )c .D  k λ .N endo (t)
dt

Equation (2)

where kendo is the rate of endocytosis (in units of inverse time), Namg is the number of amino
groups per particle, c is an empirically determined fit factor, kλ accounts for cellular replication
and D is the molar dose. Assuming a cell duplication half life of 24hrs, kλ has a value of
(0.69/24)hr-1.
After endocytosis, nanoparticles generate ROS and this build-up of ROS is counteracted by the
intrinsic intracellular anti-oxidants, in this study exemplified by GSH, and the interaction
quenches both the levels of ROS and GSH. These processes have previously been described by
Equations 3 and 4.38
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dN ROS
 k ROS .G.N endo ( t )  k q .N ROS ( t ).N GSH ( t )
dt

Equation (3)

dN GSH
 k GSH  N ROS ( t ).N GSH ( t ).k q
dt

Equation (4)

The first term in Equation 3 is a generation (G) and dose (D) dependent term describing
continuous ROS generation at a rate kROS (NROS(0) = 0). The second term describes the quenching
of the ROS at a rate kq, and depends on both; ROS levels, NROS, and antioxidant levels, NGSH
(NGSH(0) = 0). In the study by Mukerjee et al., the antioxidant levels were represented by the
experimentally measured values of Glutathione (GSH).38 In Equation 4, the experimentally
observed linear increase of the control levels of GSH, at a rate of kGSH, is described by the firstterm, and the second-term, which is the same as in Equation 3, describes the quenching of the
GSH levels. Values of kGSH and kq are derived from the experimental data and simulations of
Mukherjee et al.38
The subsequent, experimentally observed, cascade of cellular responses can be similarly
simulated. The cascade elements examined were: caspase activation, mitochondrial membrane
potential decay (MMPD), tumour necrosis factor alpha (TNF-α) and interleukin-8 (IL-8) for
HaCaT cells, or interleukin-6 (IL-6) for mouse macrophages. In the model of Mukherjee et al.,38
the early stage caspase activation and MMPD are both a result of increased levels of ROS,
although through independent pathways. Thus:

dN Casp
dt

 k Casp .N ROS ( t )  k Casp 2 .N Casp ( t )
Equation (5)
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dN MMP
 k MMP .N ROS (t)  k TNF .N MMP (t)
dt

Equation (6)

dNTNF
 k TNF .N MMP (t)  k IL-8 .N TNF (t)
dt

Equation (7)

dN IL-8
 k IL-8 .N TNF (t)
dt

Equation (8)

Again, in Equations 5 to 8; N describes the respective populations at time (t) and k the respective
rates and the initial conditions for all cases are such that N(0) = 0. Overall, these equations show
a possible cascade of events involving; ROS production, parallel rather than sequential processes
of caspase activation, loss of MMP, the latter leading to activation of TNF-α and IL-8, as
described for HaCaT cells exposed to PAMAM dendrimers by Mukherjee et al.38
Cell viability was monitored using the MTT assay.16,17 MTT measures the mitochondrial activity
and is thus experimentally most associated with changes in the mitochondrial membrane
potential, loss of which can, at certain levels, lead to apoptosis. The following equation was used
to calculate the change in the population of viable cells, NV:

dN V
 k Rec .N MMP (t) b .N V (t)  k V .N MMP (t).N V (t)
dt

Equation (9)

The second term of Equation 9 describes the process of cell death, dependent on the change in
the mitochondrial membrane potential, and the number of viable cells. As not all cells would
undergo apoptosis as a result of loss of MMP, the first term of Equation 9 allows for a process of
cell recovery, at a rate kRec, and an empirically determined sub-linear dependence (b) on NMMP
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makes this process more prominent at lower doses. NV is initially set equal to a value of 1 to
represent 100% cellular viability.
The phenomenological rate equation model thus enables simulation of the time evolution of the
cellular responses as well as the measured cytotoxic response.
Notably, the only particle dependent parameters are the nanoparticle dose (D) and generation (G).
It is demonstrated that the model can reproduce the experimentally observed variations of
cytotoxic response as a function of dose and generation, as well as measurement time-point and
the dependence on cell-line parameters such as intrinsic intracellular antioxidant levels.
Temporal Evolution
For a fixed dose and generation, the temporal evolution of the cellular responses has previously
been faithfully simulated using the rate equation model with the HaCaT cell-line.38 The model
can be extended to the J774A.1 cell-line, for G4 exposure at a fixed dose of 1M, as shown in
Figure 1 (experimental data reproduced from Naha, P.C. et al, 201017). Experimental data (as
symbols) is shown only for ROS and TNF-α as well as the temporal dependence of the MTT
viability assay (as symbols and dotted line as a guide to the eye). The solid red line indicates the
simulated ROS production and the other dotted lines show the temporal evolution of: Caspases
(Green), MMPD (Orange) and TNF-α (Purple) as simulated according to Equations 3 to 8. For
both experimental and simulated data, results are normalised to a maximum value of 1 for
visualisation purposes, with the exception of the MTT data (viability – blue dotted line), which
experimentally have been normalized to the unexposed control17. Parameters employed for the
simulated data of Figure 1, and for all subsequent figures, are listed in Supplemental Information,
Table S1. The sensitivities of the temporal, dose and generation dependences of the simulated
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data to variations of these parameters are analysed in the Discussions and Conclusions section,
and, where appropriate, in the Supplemental Information.

Figure 1. Experimental (from Naha, P.C. et al, 201017) and simulated cellular responses of
J744A.1 murine macrophages to exposure to G4 PAMAM dendrimers at a fixed dose of 1M.
Results are normalised to a maximum value of 1 for visualisation purposes, with the exception of
the MTT data (viability), which experimentally have been normalized to the unexposed control.

ROS Dose Dependence
The rate equation model can therefore be applied to simulate the temporal evolution of the
cellular responses to exposure to PAMAM dendrimers at a fixed dose. Furthermore, in the
16

previous study by Mukherjee et al., the generation dependences of Equations 2 and 3 were seen
to faithfully reproduce the experimentally observed more rapid onset of ROS production with
increasing dendrimer generation.38 Notably, however, using a constant ROS generation rate, kROS,
the ROS levels were found to increase monotonically as a function of time, and it was found
necessary to constrain the rate of generation to decrease, dependent on the amount of ROS
generated, indicative of a depletion of the source of ROS. In the preliminary model of Mukherjee
et al,38 this was achieved through the relationship of Equation 10.

dk ROS
 k ROS .N ROS ( t )
dt

Equation (10)

While this approach allowed the faithful reproduction of the temporal evolution of the ROS
levels, it does not accurately model the complex dose/generation dependence of the ROS levels
at a fixed time point, as shown in Supplementary Information Figure S1. Figure 2 shows the dose
and generation dependent levels of ROS in the J774A.1 cell-line, expressed as the percentage
increase in Carboxy-H2DCFDA fluorescence compared to control, at a fixed timepoint of 4hrs
(data derived from Naha, P.C. et al, 201017).
The dose dependence of Figure 2 can however be reproduced by considering that the increased
levels of ROS are the result of an interaction of the endocytosed nanoparticles with an
intracellular source of ROS, Nsource, which is depleted by the ROS generation process. Thus,

dN Source
  k A .G * .(N endo (t) A ).(N Source (t) B )
dt

Equation (11)
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where kA is the interaction rate for the nanoparticles and source, G* is a generation dependant
factor and the values for A and B are empirical constants. The generation of ROS, previously
described by Equation 3, is then described by:

dN ROS
 k A .G * .(N endo (t) A ).(N Source (t) B )  k q .N ROS (t).N GSH (t)
dt

Equation (12)

The continuous lines of Figure 2 show the simulation of the dose and generation dependent
increase in ROS in the J774A.1 cell-line, as calculated at 4hrs, in comparison to the
experimentally observed values. The simulated data are expressed in arbitrary units, and have
been scaled to give a best match to the experimental data. Experimentally, a background level of
~ 10% was observed at even the lowest doses and thus the simulated data, which begins at a
value of zero, are offset for comparison.
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Figure 2. Experimentally observed (symbols) (expressed as the % increase in CarboxyH2DCFDA fluorescence compared to control, at a fixed timepoint of 4hrs17) and simulated
(lines) dose and generation dependent intracellular ROS generation after 4hr exposure of
J744A.1 mouse macrophages to PAMAM dendrimers.
The simulated data of Figure 2 are generated from Equations 1-14, simultaneously for all three
dendrimer generations, with only G and D as variables. The closest simulated reproduction of the
experimental data was achieved using a generation dependent expression of G* and A, with a
constant value of B = 3, such that:


1

G*  
 N 0.25 
 amg


 N amg
A  
 64






0.75

Note, in the simulated data of Figure 2, a value of 0.25 was used for “c” of Equation 2. The
initial value of Nsource(t=0) was chosen to be 10M, the maximum dose level used in the
simulation.
The simulation faithfully reproduces the dose and generation (number of surface amino groups)
dependence of the production of ROS. Notably, for each generation, the maximum levels of ROS
production saturate at the same value, consistent with experimental observations supporting the
proposition that the surface amino groups are the primary source of the response to the
nanoparticle intake.24 The evolution of the equations (from Equation 10 to Equations 11 and 12)
to account for the dose dependence of the ROS response has little effect on the temporal profiles
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of the cellular responses at a fixed dose, and the responses represented in figure 1 are calculated
using the latter formalism rather than that of Equations 3 and 4.
Experimentally, the evaluation of the dose (7 dose measurements) and generation (3 generations)
dependent increases in ROS levels as well as their temporal evolution (1-24hrs) is an extensive
series of measurements, in independent triplicates. Having established a model which can
faithfully simulate the responses of the cell line, a 3-D representation of the combined and
continuous dose dependence and temporal evolution can be constructed, as shown in figure 3 for
the case of G4. Similar 3-D representations can be constructed for G5 and G6, and the model can
be readily extrapolated to higher and lower generations. Although the 2-D representation of the
3-D system does not do it justice, the view illustrates the importance of considering the3-D plane
in the system response.
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Figure 3. A 3D graph showing both the simulated time and dose dependence of the ROS
evolution, in J744A.1 mouse macrophages, upon G4 PAMAM nanoparticle uptake.

Cellular Viability
It is clear that the approach of the phenomenological rate equation model can accurately
reproduce the experimentally observed cellular responses, as a function of dose and generation,
as well as their temporal evolution. For the given cell-line, the responses are determined by the
surface reactivity of the nanoparticles, which, in the case of PAMAM dendrimers presented here,
depends on the number of surface amino groups per particle for each generation. Ultimately, the
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response to nanoparticle exposure is reduced viability in the in vitro culture, as measured by
cytotoxicological assays such as MTT, and normally represented by the EC50. It has previously
been shown that the cytotoxicity of PAMAM dendrimers is systematically dependent on
generation, but, given the complex dose and temporal responses, the exact link to nanoparticle
structure and reaction mechanisms has not been elucidated.
Figure 1 also plots the experimentally observed MTT EC50 value at different time points (from
Naha, P.C. et al, 201017). For a given generation, the dose dependence of the reduction in
cellular viability at different timepoints can be simulated according to Equation 9. Figure 4
illustrates the simulated dose dependence of the cellular viability, for a single generation (G4), at
6hrs, 12hrs and 24hrs, compared to the corresponding experimentally observed MTT response at
these timepoints (from Naha, P.C. et al, 201017). All parameters used to simulate the dose
dependence of the ROS (figure 2) as well as the temporal evolution of the cellular responses
(figure 1) are kept constant and only the dose is varied. A value of 0.25 was employed for the
parameter b in Equation 9. The model, with reasonable accuracy, reproduces the in vitro cellular
responses observed experimentally. The simulated results are best matched to the experimental
responses at the earlier (6hr) and later (24hr) timepoints. The deviation from the observed
responses at the intermediate timepoint (12hrs) may be the result, for example, of more complex
quenching mechanisms not included in the model at this stage.
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Figure 4. Experimental (symbols) and simulated (lines) dose dependent viability, as measured
using the MTT assay, for J744A.1 murine macrophages at 6hr, 12hr and 24hr (experimental data
from Naha, P.C. et al, 201017).
By varying the generation (G), for a fixed time point, the dose dependence of the cellular
viability for each generation can be similarly qualitatively reproduced, as shown in figure 5, for
the case of 12hr exposure of mouse macrophages (experimental data derived from Naha, P.C. et
al, 201017).
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Figure 5. Experimental (symbols) and simulated (lines) dose dependent J744A.1 mouse
macrophage viability at 12 hrs, as measured using the MTT assay, for PAMAM generations G4,
G5 and G6 (experimental data from Naha, P.C. et al, 201017).
Similar to the case of the ROS, a 3-D representation of the simulated cytotoxic response of
HaCaT cells to PAMAM dendrimer exposure, as a function of dose and time, can be constructed,
as shown in Figure 6 for the case of G4. A similar representation can be made for G5 and G6,
and the model is readily extendable to higher or lower PAMAM generations.
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Figure 6. 3D simulated time and dose dependence of MTT response for exposure of J744A.1
murine macrophage cells to PAMAM G4.
The experimental data of Figure 5 is a typical representation of a cytotoxicological screening of
nanoparticles. In comparing the responses of the cell line to the different generations in the
dendrimer series, a systematic structural dependence of the response is clear. The application of
the model presented here demonstrates that that dependence is derived from the number of
surface amino groups per dendrimer generation, and the rate of generation of ROS. The true
value of any such model, however, depends on its applicability to a range of different
experimental scenarios.32 One notable source of diversity in the literature on in vitro
nanotoxicology is the range of different cell lines used, often justified as models for target organs
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in vivo. Indeed, in the work of Naha et al., and Mukherjee et al., a range of different cell lines
were employed.16,17,23,24,38 In addition to the murine macrophages already described in this
manuscript17, the human colon adenocarcinoma cell line (SW480) and the immortalised human
keratinocyte line (HaCaT) were employed as models of ingestion and transdermal transport of
nanoparticles respectively.16,23,38 Notably, the different cell lines gave significantly different
results for the cytotoxicity of PAMAM dendrimers, as shown in figure 7 for the examples of the
dose dependent viability as measured using the MTT assay upon exposure of the different cell
lines to PAMAM G4 for 24hrs. Although an extrapolated EC50 from the J774A.117 and SW48016
cell lines would yield similar results, the value for HaCaT16 is considerably higher, indicating a
greater resistance of the skin cell line to external insult, as may be expected.
Variability: Cell lines and Assays
Following the cascade of cellular responses after nanoparticle endocytosis, described in Figure 1
and represented by Equations 2-14, a potential source of the differences in cell type responses to
nanoparticle exposure is the constituent levels of cellular antioxidants, redox enzymes etc., which
help the cell to protect itself from the oxidative stress caused by an external agent. For example,
the average activities of three important intracellular redox agents, glutathione (GSH),
glutathione-S-transferase, and glutathione reductase are approximately three times higher in
WI38 human fibroblast cells than in HaCaT cells and therefore, upon 24 h exposure to arsenic,
HaCaT cells have been reported to be 50% more susceptible to cell death than WI38 cells.44 Of
relevance to the study presented in figure 6, the natural intracellular glutathione (GSH) level of
HaCaT cells are reported to be 7300 nmol/mg protein44 whereas those of SW480 and J774A.1
cells have been reported to be ~40 nmol/mg protein45 and 26.7 nmol/mg protein,46 respectively.
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The higher level of antioxidants in HaCaT cells is therefore consistent with a greater resistance to
external insult. In the rate equation approach presented here, this internal resistance to oxidative
stress is represented by kGSH in Equation 6. The solid/dashed lines of figure 7 represent the
simulated viability for the different cell lines, calculated according to Equation 12, having
increased only the rate of generation of GSH for the HaCaT cell line (by a factor of 1.5), in
Equation 4, keeping all other rates constant. It can be seen that the simple change in the cell
dependent response parameter faithfully reproduces the experimentally observed differences in
response for the different cell lines. The increased levels of GSH result in a more rapid
quenching of the intracellular ROS levels, and this is manifest experimentally as an initial
maximum in HaCaT cells after 1-2 hrs,38 whereas in J774A.1 cells, the maximum is observed at
3-4 hrs (Figure 1).17
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Figure 7. Experimental (symbols) and simulated (lines) viability of different cell lines, as
measured using the MTT assay, after exposure to PAMAM G4 for 24hrs. Experimental data for
J774A.1 derived from Naha, P.C. et al, 201017. Experimental data for SW480 and HaCaT
derived from Mukherjee, S.P. et al. 201016.

Figure 8. Comparison of Experimental (symbols) and simulated (lines) viabilities as measured by
MTT, Alamar Blue and Neutral Red, for exposure of SW480 cells to PAMAM G4 after 24 hrs.
Experimental data from Mukherjee, S.P. et al. 201016. For each assay, the data has been
normalized to unexposed control.
Literature furthermore describes the use of a diverse range of endpoints to evaluate the cytotoxic
responses of cell lines in vitro. Each assay measures a different underlying cellular response or
function. As discussed above, MTT measures the mitochondrial function. Alamar Blue is a
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fluorescence based assay which is used to assess cell viability and proliferation; this is done by
measuring the innate metabolic activity via the conversion of resazurin (non-fluorescent) to
resorufin (fluorescent).47 Neutral Red is another fluorometric dye, which measures the lysosomal
activity using 3-Trimethyl-2,8-phenazinediamine, monohydrochloride, which binds to the
lysosomes of viable cells.48 Mukherjee et al. have highlighted how the different sensitivities of
the assays as a result of the exposure to PAMAM dendrimers are a manifestation of the
mechanism of interaction of the nanoparticles with the cells.38 Figure 8 reproduces the
experimental values of the dose dependent viability of SW480 cells after 24hr exposure to
PAMAM G4 as measured by the MTT, Alamar Blue and Neutral Red assays (from Mukherjee,
S.P. et al. 201016). For each assay, the data has been normalized to unexposed control.
In the rate equation model presented here, the responses of the assays are represented by different
steps in the cascade of cellular responses following exposure. The MTT response is associated
with changes in mitochondrial membrane potential, and is simulated by Equation 9. The lower
sensitivities of the Alamar Blue and Neutral Red assays indicate that they are associated with
later responses in the cascade. The Alamar Blue response can be associated with the subsequent
phase of generation of TNF-α and modelled according to Equation 13.

dN V '
 k rec '.NTNF α (t ) b .N V ' (t)  k V '.NTNF α (t ) m .N V ' (t )
dt

Equation (13)

Note that NV’ in Equation 13 represents the number of viable cells as registered by Alamar Blue.
NV’(0) = 1 represents the initial 100% viability. In modelling the experimental data of Figure 8,
for Alamar Blue, it is noted that an empirical factor of m=2 provides a good fit and a value of b
= 0.25 was again used.
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In a similar fashion, the response of Neutral Red can be associated with a later stage of the
cascade of cellular responses and simulated according to Equation 14:

dN V ' '
 k rec ' '.N IL  8 ( t ) b .N V ' ' (t)  k V ' '.N IL  8 ( t ) p .N V ' ' (t)
dt

Equation (14)

NV’’(0) = 1 represents the initial 100% viability. A good reproduction of the experimental results
is found with an empirical factor of p=3 and b = 0.25. In Equations (13) and (14), krec’ and krec’’,
and kV’ and kV’’ describe the rates of recovery of the system without apoptosis, and the rates of
change of the viability, as measured by the respective assay.
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Discussion
The phenomenological rate equation model presented here is a demonstration of how an
integrated approach to analysis of the responses of cells to nanoparticle exposure can be
employed to provide a better visualisation of the dependences of those responses on experimental
parameters such as dose and exposure time, nanoparticle characteristics (such as number of
active surface groups) and even variations in cell line and cytotoxicity assay. The model is
constructed on previous experimental observations of the cellular responses to PAMAM
dendrimers, which have systematically variable physico-chemical properties, and have been seen
to elicit systematically varied cellular responses. The mechanisms of response and their causal
nature and inter-relationships have been explored and discussed extensively elsewhere.16,17,23,38
While it is impractical at this stage to cover all such potential cellular responses, the model is
used to simulate several known cytotoxic markers, simultaneously for all 3 dendrimer
generations, and thus is at least a partial system of events. Such a system of events can be
considered as a sub-section of an Adverse Outcome Pathway49,31 and is consistent with the
approach of predictive paradigms for assessing nanotoxicological responses.50,33
The initial stage of endocytosis has previously been described using a rate equation approach for
the uptake of 40-50 nm fluorescently labelled polystyrene nanoparticles in the A549 human lung
adenocarcinoma cell line, as measured by flow cytometry.14 Endocytosis rates were measured and
simulated according to build up of cellular fluorescence, and the values of kendo in the current
model were chosen to yield similar simulated results for the build up of dendrimer nanoparticles
in the cells, as shown in supplementary material Figure S2. In contrast to the fluorescently
labelled PS nanoparticles, the dendrimers are not easily visualized within the cells and so the
cellular response of increased levels of ROS was used to guide the simulation of the time, dose
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and generation dependence of the cellular responses. Figure S4 shows the sensitivity of the
simulated dose dependent ROS generation to variations in the parameter kendo. In the current
model, the best simulations were achieved by including a generation (Namg) dependent factor in
the uptake, as described in Equation 2, with a c value of 0.25. For comparison, Supplementary
Figure S4 compares the dose dependent generation of ROS after 4hrs exposure for all 3
generations, with varying values of the parameter c. The best replication of the response for all
generations simultaneously is achieved using a value of c=0.25. In understanding the potential
significance of this factor, it is worth observing that the relationship between the diameter and
the number of surface amino groups for PAMAM dendrimers in the region of Namg = 20-1000 is
a power law of order 0.25 (data from http://www.dendritech.com/pamam.html). The nominal
diameters of PAMAM dendrimers available on the dendritech website are in good agreement
with those measured by size exclusion chromatography.51 The values of hydro-dynamic diameter
measured by Dynamic Light Scattering in PBS are somewhat larger, as may be expected, but the
values still scale systematically with generation and although a slight increase in cell culture
medium due to interaction with the medium may be inferred, no significant
aggregation/agglomeration of the particles is evident over the dose ranges measured.16 Thus, a
dependence of the rate of endocytosis on Namg0.25 may represent a dependence on the dendrimer
diameter, which varies only slightly with generation number (G4 diameter: 4.5nm, G5 diameter:
5.4nm and G6 diameter: 6.7nm 16).
The model considers the case of PAMAM dendrimers which have been demonstrated to be taken
up in mammalian cell lines by a process of endocytosis.14 However, endocytosis can be
subcategorised into four different types: Clathrin-mediated endocytosis, Macropinocytosis,
Caveolae-mediated endocytosis and Phagocytosis, all of which could be readily modelled via
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modification of the rate equation approach used in this study. It is also important to note that, for
smaller generation dendrimers, a potential for passive uptake is also possible. It would be of great
interest to continue to reduce the dendrimer size and explore the transition between the
dominance of active and passive uptake mechanisms, which could be incorporated as a parallel
uptake process using such a rate equation approach.
While a more primitive version of the model presented here was capable of reproducing the
temporal evolution of the cellular responses, and to some extent the dependence on dendrimer
generation,38 an accurate model of the complex dose dependence of the increase in intracellular
ROS is key to extending the model to simulate the dose dependent cytotoxic responses.
The intracellular levels of ROS increase upon nanoparticle endocytosis but are seen to reach a
maximum on a time scale of 1-4 hours, depending on the dendrimer generation, dose and cell
line.17,38 In the rate equation formulation presented here, this transient behaviour cannot be
reproduced simply by introduction of an anti-oxidant quenching mechanism. Rather, a limit to
the capacity of the cell to generate increased levels of ROS is inferred. This process is
represented by the reaction of the endocytosed nanoparticles with a source species, which
generates ROS, while consuming the source. The approach enables faithful simulation of both
the temporal evolution and the dose and generation dependence of the ROS.
The approach is analogous to that of the Operational Model of Agonist Activation,52 which
invoked the concept of an agonist receptor, to which the agonist binds, to produce the response.
Using the law of Mass Action at equilibrium, a faithful reproduction of a sigmoidal response
curve to a linear agonist dose was achieved, based on the agonist concentration, the receptor
concentration and the agonist/receptor dissociation rate.
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In considering the biological significance of an ROS source, Nsource, understanding the
mechanisms of ROS generation is important and has been discussed in the supplementary
information (ROS source discussion).
Although the exact process of ROS production has not been experimentally visualised, the model
can still faithfully reproduce the dose and generation dependence of the increase in ROS levels,
using Equations 11 and 12, as shown in Figure 2. All curves of Figure 2 can be modelled with a
constant value of kA. Figure S5 of the supplementary information illustrates how the simulated
dose dependent increase in the ROS levels for all three generations at a fixed timepoint of 4hrs
depends on variation of the parameter kA. This value is normalised by the factor G* = Namg-0.25.
The sensitivity of the simulations to the exponent of this parameter is shown in Figure S6.
Notably, this is the inverse of the factor employed for Equation 2, and, in the light of the
discussion above, can be related to the generation dependence of the dendrimer diameter.
For a given dendrimer generation, the rate of generation of ROS is dependent on
Nendo(t)A.NSource(t)B. As the dose (D) is expressed as the molar dose, for ease of comparison with
the experimental data, Nendo is an expression of the molar quantity of endocytosed dendrimer
nanoparticles. Figures S7 and S8 demonstrate the sensitivity of the simulated dose dependent
ROS generation on the parameters A and B respectively. The dependence of the power law factor,
A, on the number of amino groups, Namg, is a reflection of the increasing reactivity per dendrimer
nanoparticle with generation. The value of B=3 indicates that, in the reaction process, 3 source
species are involved.
In understanding the influence of the different parameters of Equation 12 on the form of the dose
dependent ROS generation of Figure 2, and by analogy to the Operational Model of Black and
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Leff,52 kAG* is largely responsible for the EC50 of the curves, while the factors A and B govern
the Hill slope, A accounting for the observed dendrimer generation dependence.
It is however important to note that for these well defined structures, the nanoparticle diameter,
number of surface amino groups, and surface area all scale with generation number and are
therefore intimately related. It has also been previously demonstrated that the (positive) zeta
potential scales with increasing generation and therefore surface area and number of surface
amino groups Namg16. In cell culture medium, the zeta potential for all generations becomes
negative due to interaction with the medium and scales with the generation, surface area and
therefore Namg, and notably, the magnitude of the change in the zeta potential scales with the
dendrimer surface area. For both the SW480 and HaCaT cell line, the EC50 for a range of assays
(Neutral Red, Alamar Blue, MTT (all 24hrs) and the clonogenic assay (8 day)) has been seen to
scale with the surface area, the zeta potential in cell culture medium, and the change in zeta
potential from distilled water to cell culture medium. Zeta potential depends on the dispersion
environment, however, and is not an intrinsic nanoparticle parameter, compared to the number of
surface amino groups, which is compositionally defined. A similar systematic correlation
between the toxic response and the number of surface amino groups has been demonstrated for
J774A.1 mouse macrophages.17
Using only G as a nanoparticle dependent variable, resulting in a reaction rate which is dependent
on the systematically varied physico-chemical structure of the dendrimer nanoparticles, the
experimentally observed dose and time dependent ROS generation can be simultaneously
simulated for all three dendrimer generations. Using this as the initiation stage of an intracellular
response cascade, the subsequent changes in viability of the cell population at different
timepoints, as measured using the MTT assay, can be modelled simultaneously using the
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relatively simple rate Equation 9. As MTT primarily monitors changes in mitochondrial activity,
changes in cell viability are related to the time dependent MMPD, as simulated by Equation 6.
The sensitivity of the simulations to the parameter kMMP of Equation 6 is shown in
Supplementary Information Figure S9. It is noted that, using this relatively simple formalism, an
accurate simultaneous reproduction of the experimental results at all timepoints is not achieved.
This is not surprising as the cascade process of cytokine activation/production and resultant
changes to mitochondrial activity is more complex than that considered here. The first term of
Equation 9 allows for changes in MMP without reduction of cell viability as measured by the
MTT assay, but this did not significantly improve the simultaneous simulation of the dose
dependent viability at different time points.
Similarly, Equation 9 can be employed to simultaneously simulate the cytotoxicity for all three
generations, at a fixed timepoint. In figure 5, the simulation provides an accurate reproduction of
the experimental data, although the low dose behaviour is less well reproduced. Again, this is
most likely a result of the relative simplicity of the model system, which doubtless does not
include many processes which are occurring in parallel with those experimentally measured and
considered in the model. Figure S10 of the Supplementary Information explores the sensitivity of
the simulated viability to the parameter kMMP. No significant improvement in the discrepancy at
low doses is achieved, although the simulated curves of Figure 5 fall largely within the
experimental error margins.
A potential pitfall of such modelling approaches can be 'over parameterisation' with insufficient
experimental data that ultimately leads to 'over fitting'. In modelling the system, the minimum
number of sequential processes have been included to describe the system, as observed
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experimentally. Additional steps in the cascade can be added, as they are elucidated
experimentally or by for example pathway enrichment approaches.
It should be noted that the ROS response to PAMAM nanoparticle exposure has been observed
to be a two stage response,38 and only the initial stages are modelled here. The initial response (06 hrs) has been associated with encapsulation of the dendrimers in endosomes, while the later,
secondary response has been associated with release of the nanoparticles into the cytoplasm by
endosomolysis and subsequent incorporation into the mitochondria. A similar behaviour was
observed by Xia et al. (2006)12 for ROS generation by aminated polystyrene nanoparticles. While
the second phase of ROS generation is not modelled here, a similar rate-equation approach could
be employed to simulate the responses, their time evolution and dependences on dose and
dendrimer generation. A more complete understanding of generation and dose dependence of the
process of endosomal-rupture, particle migration to and uptake by the mitochondria, and
recovery of intracellular antioxidant levels would be required. Between the two phases, such
phenomena as the quenching of ROS levels to below those of controls, the recovery of
antioxidant levels, and migration of antioxidants to localised subcellular sites should be
considered. Nevertheless, the phenomenological model is readily adaptable to include more
complex phenomena, simply by adding additional terms to the rate-equations. However, it should
be noted that while the ROS generation of figure 2 relates exclusively to the early stages of
intracellular nanoparticle interactions, the later responses, in particular the later time point
viability measurements, may be influenced by the secondary phases of ROS generation.
Nevertheless, the model provides a valuable visualisation of the range of cellular responses to the
exposure to nanoparticles and a faithful qualitative reproduction of the nanoparticle structural
and dose dependences of the cytotoxic responses based on independent nanoparticle and cell
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dependent reaction rates. Notably, experimentally observed differences between the responses of
different cell lines can be simulated simply by adjustment of cellular passed parameters, in this
case the rate of production of GSH, based on established differences in cell-line metabolism. In
this context, the robustness of the model can be further validated by monitoring variations of
ROS production and cytotoxic responses as a result of externally controlled antioxidant
levels.13,53,54,55,56reviewed by 57
Furthermore, the model also elucidates the origin in the differences of the responses of
commonly used cytotoxicity assays and clarifies that lower observed values of EC50 for different
assays as a measure of the same nanoparticle/cell-line system are an indication that the assays are
registering cellular responses at later stage in the response cascade. Although the time responses
have not explicitly been measured, the simulations of Figure 8 indicate that the variations of
responses can be well modelled by Equations 13 and 14, which have the same form as the
viability simulations of Equation 9, keeping all parameters of the earlier stage responses constant.
Figure S11 shows the variability of the fits to changes in the parameters m and p.
The use of such rate equation models for the simulation or fitting of complex systems is by no
means novel and has become more prevalent in pharmacokinetics/pharmacodynamics.58,59 In
terms of nanobio interactions, Salvati et al. employed a rate equation approach to model the
uptake of polystyrene nanoparticles in cells as measured by the fluorescent response of the cell
populations, although no modelling of the cellular responses was undertaken.14 Dell’Orco et al.
used a similar approach, described in terms of Systems Biology, to model the delivery success
rate of engineered nanoparticles and its dependence on the presence and structure of the protein
corona.60 To our knowledge, however, this is the first use of such models to simulate the time
evolution, dose and structural dependence of cellular responses to nanoparticle exposure and to
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derive toxicological endpoints from the simulated data. Undoubtedly, the approach is crude at
this stage, and improvements based on fitting of the data by for example nonlinear regression59 or
parameter global sensitivity analysis (GSA)60 could significantly enhance the robustness of the
model. Parameter GSA simultaneously varies all the parameters within the parameter space to
evaluate their effect on the system.60 Program packages are available to aid this analysis, such as:
SBML-SAT (Systems biology markup language - sensitivity analysis tool). This program allows
for evaluation using a range of different methods, including Sobol’s Method, Weighted average
of local sensitivity analysis, multi-parametric sensitivity analysis and partial rank correlation coefficient. The program can also handle discontinuous events, which could be beneficial for the
system in question.61 While this sort of modeling shows potential for the future it is worthy to
note that uncertainty still remains an issue. For example a study by Bennett et al, shows that
when calculating one parameter using a range of different models, the results can be orders of
magnitude in difference.62 Differences will always be present in these models as different models
utilize different methods for prediction. However, the scale of the differences should be reduced,
particularly by larger validation sets and more detailed applicability domains.
Nevertheless, the model helps to visualise the complex range of responses which can occur upon
exposure of in vitro cell cultures to nanoparticles. The experimentally observed cascade of events
resulting from oxidative stress and subsequent inflammatory responses can readily be modelled.
The dose dependence is complex, but can be modelled and related to the nanoparticle physicochemical properties. Critically, the model demonstrates the temporal responses are dynamic and
the dose dependences are complex, and therefore that it is not sufficient to measure cellular
responses at a fixed dose or time point. Ideally, the complete 3-D profile of time, dose and
response should be measured for all particles, structural variations, assays and cell-lines. Such an
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exercise would be exhaustive, in terms of time and cost, however, and numerical simulation
models such as the one presented here can be of great benefit in reducing the effort.
Notably, the model allows to differentiate the impact on the viability endpoint of nanoparticle
based parameters from cellular based parameters, and for a single cell line, the entire range of
responses to the exposure to three different dendritic nanoparticles has been reduced to the two
parameters of rate of endocytosis and rate of ROS generation. Within a single cell line, the
differing responses of the different cytotoxicity assays are consistent with sensitivity to different
stages of the cellular response cascade. Extending to different cell-lines, the variation of response
can be accounted for by differences in intracellular antioxidant levels, although cell-line
dependent differences in rate of endocytosis and rate of ROS generation, for the same
nanoparticles cannot be ruled out and need to be experimentally verified.
The representation of the cellular responses in terms of a causally related sequence of events
leading to cell death lends itself naturally to an AOP formalism, and such a formalism can be
advantageous to regulatory bodies as it will identify the critical step in the sequence leading to a
toxic response, in this case ROS production. Although AOPs developed to-date are primarily
qualitative in nature, the work described in this manuscript could be described as modelling a
'partial' AOP or Toxicity Pathway that comprises events at the molecular and cellular level.
Additionally, the systems biology like approach adds quantification of the rates of response,
which are related in the initial stages to the physico-chemical properties of the nanoparticles. By
coupling these two approaches it may be possible to calculate an amount or rate of ROS
production, from which the cell cannot recover, which would form the cut off point (acceptable
limit) of whether the nanoparticle would be considered dangerous or not. Of course cellular
quenching of ROS via antioxidant activity would also have to be considered. Such an approach
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may ultimately lead to predictive models of cytotoxic response and the basis of QSARs. In terms
of the development of QSARs, the study and modelling of homologous series of nanoparticles
contributes greatly to interpreting the mechanism of response, but also quantifiably relating the
endpoint (EC50) to the nanoparticle physico-chemical properties. The model further indicates, at
least within the homologous series presented here, that the determining factor of the toxic
response is the rate of generation of ROS, and that this may be considered a defined endpoint for
the construction of QSARs. Obviously, the domain of applicability of such a model would need
to be expanded by studies of a broader range of polymeric and other nanoparticles whose surface
chemistry is well defined and ideally systematically variable. Only then can a reliable statistical
validation of reliability and robustness of the model be considered. In constructing the model,
simulations have been performed simultaneously for either: three dendrimer generations (Figures
2 and 5), timepoints (Figure 4), cell lines (Figure 7) or assays (Figure 8), keeping all other
parameters constant. This suggests that, once the model has been established, it should be readily
extendable to, for example, further generations of PAMAM dendrimer, similar homologous
cationic dendrimer series such as Poly(propylene imine), or other aminated polymer
nanoparticles such as polystyrene and that the responses should be quantitatively predictable
based on the number of surface amino groups. Work is ongoing to demonstrate that the model
can be quantitatively translated to such systems, and thereby demonstrate a broader domain of
applicability. Ultimately, it may be possible to characterise the surface reactivity, and thus the
rate of generation of ROS acellularly, such that the model could the readily be extended to other
more complex particle types that act via ROS mediated cellular stress pathways such as metal
oxides, and the parameter may be used as input into such a model to predict the in vitro
cytotoxicity.
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Conclusion
The plethora of in vitro studies of nanoparticle toxicity demand that a more structured approach
to classification and understanding. In this context, homologous series of particles of
systematically variable physico-chemical properties play an important role, and the
systematically varied cellular responses facilitate the development of mathematical models based
on the mechanisms of response.
This study demonstrates how such an approach can be used to faithfully reproduce and visualise
the time and dose dependant response, for three polymer dendrimer nanoparticles
simultaneously, and to construct a 3D toxicity profile to model the structurally dependent
nanoparticle uptake and resultant oxidative stress and inflammatory cascade, leading to apoptosis
and cell death. The phenomenological rate equation approach lends itself naturally to tracking the
kinetics of the response, but the dose dependent toxicological end point at a fixed time point can
similarly be modelled.
The model is also readily extendable to different cell lines, simply by changing a cell based
parameter such as kGSH and while the full range of components of the inflammatory/apoptotic
cascade have not yet been experimentally visualised, the model can replicate the results of the
cytotoxicity assays by solving for viability at different steps in the sequence. Furthermore, the
system of equations used is versatile and can be readily modified to include additional cascade
steps and new parameters as the experimental data become available.
Work is ongoing to apply the model to a range of different particles and cell lines. This current
work serves to show that these mathematical models hold potential in predicting nanoparticle
toxicity and will, with further development, provide a viable alternative to testing of each particle
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via a case-by-case approach. The models also have potential uses in a regulatory capacity and by
combining these quantative methods with qualitative methods (such as AOPs) it will be easier to
evaluate and apply limits of acceptability to the toxic response.
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Supplementary Information:
Table S1: Parameters employed for the final simulated datasets.
dt

0.1 hr

kA

0.0011 hr-1

RT0

10M

kendo

0.75 hr-1

c

0.25

kGSH

1.00 hr-1

kq

0.40 hr-1

kλ

(ln2/24) hr-1

B

3
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Nsource(t=0)

10M

kcasp

0.02 hr-1

kcasp2

0.30 hr-1

kmmp

0.001 hr-1

ktnf

0.035 hr-1

kil8

0.10 hr-1

kV

8.00 hr-1

krec

0.065 hr-1

kROS

1.20 hr-1

In previous workSR1, the time dependent rise and subsequent decay of the generation of ROS was
modelled according to equation (10). However, such a model does not accurately account for the
observed dose dependence, as shown in figure S1. Although an initial saturation-like behaviour
is observable at intermediate doses, at higher doses the levels of ROS continue to increase
monotonically.
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Figure S1: Dose dependent ROS generation for all generations simulated according to Equation
10.
The experimentally observed dose and time dependence of the increased levels of ROS is
faithfully reproduced, however, by invoking the concept of a source of ROS which is depleted
according to Equation 11, resulting in a dose and time dependent generation of ROS according to
Equation 12 as shown in Figure 2.
Figure S2 shows the simulated uptake of nanoparticles, Nendo, calculated according to Equation 2,
for PAMAM generations G4, G5, G6, with values of c = 0.25, k

= (ln2/24)hr-1. Similar to the

behaviour observed by Salvati et al.SR2 for aminated polystyrene nanoparticles, the response
increases approximately linear at early times, but deviates from linearity as the cells divide and
the nanoparticles are distributed over a larger cell population. Although no values of kendo are
quoted by Salvati et al., the experimental data in their study are best fitted by a regime in which
kendo>k . In figure S1, kendo = 0.75 hr-1 > k = 0.03 hr-1.
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Figure S2: Simulated time dependent uptake of PAMAM dendrimers of generation G4, G5, G6,
according to Equation 2, at a fixed dose of 1 m.
The effect of variation in kendo is also manifest in the dose dependent evolution of the ROS levels
for all generations, as shown in Figure S3, for the example of 4hrs exposure. Variation of kendo
has the effect of systematically shifting the median dose point of ROS increase. The best
reproduction of the experimentally observed behaviour for the combined dataset of three
dendrimer generations was found with kendo=0.75 hr-1.

ROS

Source

Discussion

Confocal microscopic studies of mammalian cell exposure to PAMAM dendrimers by Mukherjee
et al. have clearly demonstrated co-localisation of the early stage ROS with endosomes.SR3,SR4 In
the case of cationic nanoparticles in the acidifying environment of endosomes, it is reported that
the unsaturated surface amino groups sequester protons that are supplied by the v-ATPase
58

(proton pump).SR5 This process keeps the pump functioning and leads to the retention of one Cl–
ion and one water molecule per proton. It has been proposed that the initial wave of ROS may be
produced via NADPH oxidase.SR6 NADPH oxidase is an enzyme which produces superoxide
anions (O2-) in phagosomes and endosomes.SR7 Evidence also points to the release of the
superoxide to the cytoplasm via chloride anion channels.SR7 Superoxide production is
accomplished by an electron transfer from NADPH, via FAD, to molecular oxygen (O2). The O2then rapidly dismutases to hydrogen peroxide (H2O2).SR8 It is also believed that the protons from
the proton pump mechanism are used in the dismutation of superoxide. NADPH oxidase is
present in nearly all cell types (including HaCaT cellsSR9) and is important in both host defences
and redox signalling. Reviewed by SR10 and SR11 NADPH oxidase has been implicated in the production
of ROS in nanoparticle induced toxicity for other nanoparticles, including silica, etc.SR12,SR13 The
idea that NADPH oxidase is responsible for PAMAM induced toxicity deserves further attention
and may aid in a deeper understanding of the underlying processes involved in nano-cytotoxicity.
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A:

Figure

S3-A:

kendo

=

0.25hr-1

S3-B:

kendo

=

0.75hr-1

B:

Figure
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C:

Figure S3-C: kendo = 1.25hr-1
Figure S3: Variation in simulated (lines) increase in ROS levels on the parameter kendo in
Equation 2, compared to experimental data (symbols) for G4, G5, G6. A: kendo = 0.25hr-1, B:
kendo = 0.75 hr-1, C: kendo = 1.25hr-1.

The generation dependence of the uptake (also demonstrated in Mukherjee, S.P. and Byrne H.J.
2013SR1) derives from the term (Namg)c in Equation 2, and although the uptake of the dendrimers
cannot be directly visualised, the effect of this term on the generation dependent increase in ROS
levels is demonstrated in figure S4. The generation dependent factor similarly has the effect of
shifting the dose dependent curves along the dose axis, but also systematically varies the
separation of the responses for the different dendrimer generations. The best reproduction of the
ROS curves was obtained using a value of c=0.25, as shown in figure S4:B.
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A:

Figure

S4-A:

c

=

0

B:

Figure S4-B: c = 0.25
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C:

Figure S4-C: c = 1
Figure S4: Variation in simulated (lines) increase in ROS levels on the parameter (Namg)c in
Equation 2, compared to experimental data (symbols) for G4, G5, G6. A: c = 0, B: c = 0.25 and
C: c = 1.

Figure S5 illustrates the sensitivity of the simulations to variations in the parameter kA in
Equations 11 and 12. The parameter largely impacts on the separation of the dose dependences of
the different generations. The best reproduction of the experimental behaviour was observed with
a value of kA = 0.0011 hr-1.

63

A:

Figure

S5-A:

kA

=

0.0004

hr-1

S5-B:

kA

=

0.0011

hr-1

B:

Figure

64

C:

Figure

S5-C:

kA

=

0.0018

hr-1

Figure S5: Variation in simulated (lines) increase in ROS levels on the parameter kA compared to
experimental data (symbols) for G4, G5, G6. A: kA = 0.0004 hr-1, B: kA =0.0011hr-1 and C: kA =
0.0018 hr-1.

Figure S6 shows how the dose dependant ROS values vary with the G* parameter. Since G* =
1/(Namg0.25) the variance was observed by changing the exponent value (0.25).
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Figure S6-C: Exponent value = 0.42
Figure S6(A-C): Variation in simulated (lines) increase in ROS levels on the exponential value in
the equation G*=1/(Namg0.25), compared to experimental data (symbols) for G4, G5, G6. A:
Exponent value = 0.083, B: Exponent Value = 0.25, C: Exponent Value = 0.42.
Figure S7 shows how the dose dependant ROS values vary with the parameter A. Since A =
(Namg/64)0.75 the variance was observed by changing the exponent value (0.75).
A:

Figure

S7-A:

Exponent

value

=

0.25

B:
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Figure

S7-B:

Exponent

value

=

0.75

C:

Figure S7-C: Exponent value = 1.25
Figure S7(A-C): Variation in simulated (lines) increase in ROS levels on the exponential value in
the equation A=(Namg/64)0.75, compared to experimental data (symbols) for G4, G5, G6. A:
Exponent value = 0.25, B: Exponent Value = 0.75, C: Exponent Value = 1.25.
Figure S8(A-C) shows how the does dependant ROS production varies with the parameter B of
Equations 11 and 12. It can be seen that this parameter has a dramatic effect on the overall shape,
dose and generation dependence of the curves. A best reproduction of the experimental
behaviour was obtained with B=3.
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Figure

S8-B:

B

=

3

S8-C:

B

=

5

C:

Figure

Figure S8: Variation in simulated (lines) increase in ROS levels on the parameter B in Equation
11/12, compared to experimental data (symbols) for G4, G5, G6. A: B = 1, B: B = 3 and C: B =
5.
Figure S9 shows how the viability of the cells (for G4 at three timepoints), as calculated using
Equation (9) is affected by the parameter kMMP.
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Figure S9-C: kMMP = 0.0013

Figure S9(A-C): Effect of variation of the parameter kMMP on simulated (lines) viability
compared to experimental data (symbols) for G4 at timepoints: 6hrs, 12hrs and 24hrs. A: kMMP =
0.0007, B: kMMP = 0.0010 and C: kMMP = 0.0013.

Figure S10 shows how the viability of the cells (for 3 generations of nanoparticle), as calculated
using Equation (9) is affected by the parameter kMMP.
A:
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Figure

S10-A:

kMMP

=

0.0007

S10-B:

kMMP

=

0.0010

B:

Figure
C:

Figure S10-C: kMMP = 0.0013

Figure S10(A-C): Effect of variation of the parameter kMMP on simulated (lines) viability
compared to experimental data (symbols) for G4, G5, G6. A: kMMP = 0.0007, B: kMMP = 0.0010
and C: kMMP = 0.0013.
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Figure S11 shows how the viability of the cells, as calculated using Equation (9) is affected by
the exponent value “m” in equation 13.
A:

Figure 11-A: m=1
B:

Figure 11-B: m=2
C:
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Figure 11-C: m=3
Figure S11(A-C): Effect of variation of the parameter m (dotted line) on simulated (lines)
viability compared to experimental data (symbols) for 3 different assay types . A: m = 1, B: m =
2 and C: m = 3.
Figure S12 shows how the viability of the cells, as calculated using Equation (9) is affected by
the exponent value “p” in equation 14.

A:

Figure 12-A: p=2
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B:

Figure 12-B: p=3

C:
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Figure 12-C: p=4
Figure S12(A-C): Effect of variation of the parameter p (dashed line) on simulated (lines)
viability compared to experimental data (symbols) for 3 different assay types . A: p=2, B: p=3
and C: p=4.
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